ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,401, issued on April 29, was assigned to DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION (Daegu, South Korea).

"Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer" was invented by Jun Woo Kim (Daegu, South Korea), Sang Hyun Min (Daegu, South Korea), Heejin Lee (Daegu, South Korea) and Oh Bin Kwon (Daegu, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising trimebutine as an active ingredient for prevention or treatment of cancer. Having an excellent effect of selectively ...